Pertussis Vaccine Market Size, Business Growth Updates, Trends, Industry Report And Forecast To 2033

Year End Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The Business Research Company's Pertussis Vaccine Global Market Report 2024 identifies rising childbirth rates as the major driver for the pertussis vaccine market's growth in the forecast period. Childbirth is the term for the act of giving birth to a child. It is the culmination of pregnancy, during which the fetus develops in the mother's uterus and marks the beginning of a new life outside the womb. The pertussis vaccine is primarily used for children because it helps protect them from whooping cough and other severe and potentially deadly diseases.

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

Download Free Sample Of Pertussis Vaccine Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=13023&type=smp

Major competitors in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd.

A key trend in the pertussis vaccine market includes innovative approvals bolster major companies in the pertussis vaccine market. Major companies operating in the pertussis vaccine market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, announced that BOOSTRIX was approved by the U.S. Food and Drug Administration (FDA). BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap) vaccine. It is used during pregnancy to prevent pertussis (whooping cough) in newborn infants. It is injected once into the upper arm muscle. Boostrix is safe and effective for pregnant women and their babies. Additionally, it effectively prevents pertussis, including severe cases of the disease.

Read More On The Global Pertussis Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

The pertussis vaccine market is segmented -
1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the pertussis vaccine market.

The Business Research Company's "Global Pertussis Vaccine Market Report 2024" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Pertussis Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

The Table Of Content For The Pertussis Vaccine Market Include:
1. Executive Summary
2. Pertussis Vaccine Market Characteristics
3. Pertussis Vaccine Market Trends And Strategies
4. Pertussis Vaccine Market - Macro Economic Scenario
5. Global Pertussis Vaccine Market Size and Growth
……
32. Global Pertussis Vaccine Market Competitive Benchmarking
33. Global Pertussis Vaccine Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pertussis Vaccine Market
35. Pertussis Vaccine Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.